Wintergreen oil inhalation for shortness of breath in pneumonia patients
Official title: The Effects of Wintergreen Essential Oil Inhalation on Alleviating Dyspnea Among Patients With Pneumonia
Run by Far Eastern Memorial Hospital · NCT07894835 · Data updated 2026-11-12
Hospitals will test whether inhaling wintergreen essential oil helps relieve dyspnea in adults with pneumonia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 84 (estimated) |
| Sponsor | Far Eastern Memorial Hospital Academic / other |
| Locations | 1 site (New Taipei City, Taipei) |
| Status | Recruiting |
| Started | October 19, 2026 |
| Main results expected | July 31, 2028 |
| Study ends | July 31, 2028 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT07894835 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–90 with a primary pneumonia diagnosis and dyspnea, able to communicate in Mandarin or Taiwanese and without contraindicating conditions.
✕Probably not a fit
Patients with severe nasal disease, salicylate allergy, dementia, pregnancy, or on certain respiratory supports may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, non-blinded study will enroll 84 hospitalized pneumonia patients and assign them to seven groups to receive different inhaled preparations, including wintergreen oil at several concentrations, a placebo, a positive control, or routine care. Inhalations occur three times daily for three days, using a small amount of oil on gauze held near the nose for brief breaths. Researchers will measure breathing effort, oxygen levels, blood lactate, lung function, lab markers, and patient-reported comfort before and after the intervention.
Why it matters
Potential benefit: If successful, wintergreen inhalation could provide a simple, noninvasive option to ease dyspnea in pneumonia patients.
How similar studies have gone: Previous aromatherapy approaches have shown mixed results; this study explores a structured, dose-ranging inhalation strategy in pneumonia.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Primary diagnosis of pneumonia with dyspnea symptoms. 2. Admitted with ICD-10 diagnosis codes: Influenza and viral pneumonia (J10-J12), Bacterial pneumonia (J13-J15), Other infectious agents (J16-J17), or Unspecified organism pneumonia (J18.9). 3. Aged 18 to 90 years. 4. Clear consciousness (Glasgow Coma Scale: 15) with normal mental and behavioral capacity. 5. Able to communicate verbally or non-verbally and comprehend Mandarin or Taiwanese. Exclusion Criteria: 1. Dementia (including Alzheimer's disease, Parkinson's disease, etc.). 2. Acute psychiatric symptoms precluding communication. 3. Known allergy or hypersensitivity to salicylates, aspirin, or nonsteroidal anti-inflammatory drugs (NSAIDs). 4. Anosmia or severe nasal diseases. 5. Pregnant or lactating women. 6. Currently receiving non-invasive positive pressure ventilation (NIPPV, BiPAP), high-flow nasal cannula (HFNC), or oxygen masks (such as Simple mask, Non-rebreathing mask). 7. History of asthma. 8. History of very severe chronic obstructive pulmonary disease (COPD): GOLD stage 4 (FEV1 \< 30% predicted).
Where it's running
-
Far Eastern Memorial Hospital
New Taipei City, Taipei, Taiwan Recruiting
Study contacts
- Principal investigator: Shu-Ding Lin — Far Eastern Memorial Hospital
- Study coordinator: Shu-Ding Lin
- Email: lin102510015@gmail.com
- Phone: +886978291152
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulmonary and cardiovascular rehabilitation program for chronic respiratory and heart conditions
This study tests a rehabilitation program that combines exercise for people with chronic lung and heart conditions to see if it helps them feel better and improve their daily activities.
-
Observing symptoms in children with first-onset bronchial asthma
This study looks at how asthma shows up in kids and teens aged 3 to 18, especially if they have unusual symptoms like a chronic cough, to see if a specific questionnaire can help spot these cases better.
-
Assessing diaphragm function in patients with respiratory diseases
This study is testing how well the diaphragm works in people with respiratory diseases to see if it affects their breathing difficulties and overall health.
-
A large biobank for acute and emergency medicine
This study is collecting health information and samples from patients with sudden illnesses in the Emergency Department to see if it can help improve treatments and predict how patients will do.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
AI-powered CT help to guide pneumonia care
A multicenter trial tests whether using a chest CT–based AI report to guide care reduces death or need for new organ support in adults with pneumonia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.